PAOLETTI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 4.632
EU - Europa 3.858
AS - Asia 466
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.985
Nazione #
US - Stati Uniti d'America 4.625
PL - Polonia 1.626
RU - Federazione Russa 824
UA - Ucraina 290
SE - Svezia 282
IE - Irlanda 256
IT - Italia 197
DE - Germania 179
HK - Hong Kong 167
SG - Singapore 137
FI - Finlandia 85
CN - Cina 84
GB - Regno Unito 58
IN - India 39
CH - Svizzera 28
VN - Vietnam 25
FR - Francia 16
CI - Costa d'Avorio 15
SC - Seychelles 12
NL - Olanda 9
TR - Turchia 9
CA - Canada 7
JO - Giordania 5
BE - Belgio 4
ES - Italia 3
EU - Europa 1
GR - Grecia 1
MU - Mauritius 1
Totale 8.985
Città #
Warsaw 1.626
Santa Clara 798
Fairfield 511
Jacksonville 457
Chandler 375
Dublin 256
Ashburn 241
Cambridge 238
Seattle 231
Woodbridge 231
Wilmington 200
Houston 184
Singapore 106
Hong Kong 94
Princeton 86
Ann Arbor 78
Boardman 72
Buffalo 72
Boston 61
Altamura 48
Lawrence 42
Medford 36
Mumbai 36
Beijing 35
Florence 30
Bern 28
San Diego 27
New York 20
Norwalk 18
Shanghai 16
Abidjan 15
Auburn Hills 14
Moscow 14
Dong Ket 13
Frankfurt Am Main 12
Milan 12
Bremen 11
Kent 11
Phoenix 11
Hillsboro 10
Verona 10
Los Angeles 8
West Jordan 8
Izmir 7
Saint Petersburg 7
Andover 6
Toronto 6
Yubileyny 6
Central 5
Dearborn 5
Brussels 4
Salerno 4
Griesheim 3
London 3
Barcelona 2
Cedar Knolls 2
Falls Church 2
Fuzhou 2
Helsinki 2
Napoli 2
Pisa 2
Arnsberg 1
Athens 1
Bengaluru 1
Bologna 1
Cantagallo 1
Castelliri 1
Centrale 1
Hangzhou 1
Hefei 1
Jinan 1
Kilburn 1
Kunming 1
Lappeenranta 1
Laurel 1
Leawood 1
Manresa 1
Messina 1
Montréal 1
Naaldwijk 1
Nanning 1
Negrar 1
Redwood City 1
San Francisco 1
San Mateo 1
Serra 1
Shijiazhuang 1
Siena 1
Terlizzi 1
Trumbull 1
Urbino 1
Valdobbiadene 1
Wuhan 1
Totale 6.504
Nome #
HDAC1 controls CIP2A transcription in human colorectal cancer cells 279
GROWTH INHIBITION AND DIFFERENTIATION OF HUMAN BREAST CANCER CELLS BY THE PAFR ANTAGONIST WEB-2086 273
HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis. 249
Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells 248
Transketolase and 2',3'-Cyclic-nucleotide 3'-Phosphodiesterase Type I Isoforms Are Specifically Recognized by IgG Autoantibodies in Multiple Sclerosis Patients. 244
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN 238
Cholesterol esterification during differentiation of mouse erythroleukemia (Friend) cells 236
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease. 234
Enhanced proteolytic activities in cultured fibroblasts of Alzheimer patients are revealed by peculiar transketolase alterations 229
Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation 219
Inhibition of DNA methyltransferase activates tumor necrosis factor alpha-induced monocytic differentiation in acute myeloid leukemia cells. 214
Functional characterization of human ProNGF and NGF mutants: Identification of NGF P61SR100E as a "Painless" lead investigational candidate for therapeutic applications 205
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukemia cells 171
"Preparative enzymic synthesis and isolation of D-Threo-2-Pentulose 5-Phosphate(D-Xylulose 5-Phosphate)" 144
"Induction, effects, and quantification of sublethal oxidative stress by hydrogen peroxide on cultured human fibroblasts" 143
Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents 134
Characteristic transketolase alterations in dermal fibroblasts of Alzheimer patients are modulated by culture conditions 126
A cystatin-based affinity procedure for the isolation and analysis of papain-like cysteine proteinases from tissue extracts 122
The comet assay-approach to senescent human diploid fibroblasts identifies different phenotypes and clarifies relationships among nuclear size, DNA content and DNA damage 119
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring 117
Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells 112
"Analysis of transketolase and identification of an enzyme variant in human leukocytes" 111
Cysteine proteinases are responsible for characteristic transketolase alterations in Alzheimer fibroblasts 110
WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential 110
Occurrence of transketolase abnormalities in extracts of foreskin fibroblasts from patients with Alzheimer's disease 109
A spectroscopic investigation of cobalt (ii) substituted alkaline phosphatase 108
A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts 103
An enzymic method for the analysis of D-erythrose 4-phosphate. 102
Premature induction of aging in sublethally H2O2-treated young MRC5 fibroblasts correlates with increased glutathione peroxidase levels and resistance to DNA breakage 99
Brevetto # FI2007A000288 riguardante lo sviluppo di Nuovi inibitori delle Deacetilasi Instoniche. Data di deposito: 21 Dicembre, 2007 96
Transketolase from human leukocytes. Isolation, properties and induction of polyclonal antibodies 95
Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents. 95
Impaired GATA-1 expression and myelofibrosis in an animal model 93
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their Gata-1 expressione (GATA-1low mice). 93
PAF-receptor, rather than PAF, has a role in opposing AML cell growth and survival 93
Detection and estimation of sedoheptulose and octulose mono- and bisphosphates in extracts of rat liver. 93
Constitutive and inducible expression of megakaryocyte-specific genes in Friend erythroleukaemia cells. 93
Superoxide-driven NAD(P)H oxidation induced by EDTA-manganese complex and mercaptoethanol 92
Heterogeneous expression of transketolase in rat brain 92
Protein metabolism in tumor cells at various stages of growth in vivo. 91
Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias. 91
Proteolytic imbalance in Alzheimer fibroblasts as potential pathological trait of disease 90
A pathobiological pathway linking thrombopoietin, GATA1 and TGFbeta1 in the development of myelofibrosis 90
Constitutive muscarinic receptors are involved in the growth and differentiation of friend erythroleukemia cells. 90
Variegation of the phenotype induced by the GATA-1low mutation in mice of different genetic backgrounds. 90
Purification and properties of transketolase from fresh rat liver 89
The role of respiration in tumor cell transition from the noncycling to the cycling state. 89
Synthesis and cleavage of octulose bisphosphates with liver and muscle aldolases 89
Altered cholesterol ester cycle in skinfibroblasts from patients with Alzheimer’sDisease 88
Acetylcholinesterase in murine erythroleukemia (Friend) cells: evidence for megakaryocyte-like expression and potential growt-regulatory role of enzyme activity 88
A common megakaryocytic and erythrocytic precursor in murine erythroleukemia (Friend) cells? 86
Free Ca2+ levels and expression of biochemical markers in Alzheimer's fibroblasts 86
DEVELOPMENT OF MYELOFIBROSIS IN MICE GENETICALLY IMPAIRED FOR GATA-1 EXPRESSION (GATA-1LOW) MICE. 85
Immunoaffinity purification of rat liver transketolase:evidence for multiple forms of the enzyme 83
Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease 80
Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells 77
Comparative levels of DNA streand breaks and sensitivity to oxidative stress in aged and senescent human fibroblasts: a distinctive pattern for centenarians 76
Novel hydroxamate histone deacetylase inhibitors 75
Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells 75
"Multiple forms of transketolase in normal and pathological tissues" 72
Studies on the kinetics if initial cycle progression in vitro of ascites hepatoma tumour cells subsequent to isolation from ascites fluid 71
OSSERVAZIONI PRELIMINARI SULL''''ORIGINE E IL METABOLISMO DELLE PROTEINE DEL LIQUIDO ASCITICO IN RATTI PORTATORI DI EPATOMA ASCITE AH-130 DI YOSHIDA 68
"Transketolase alterations as possible hallmark of increased proteolytic activities in extracts of cultured Alzheimer fibroblasts" 67
Occurrence and significance of octulose phosphates in livre 66
Altered proteinase activities and distribution in cultured Alzheimer fibroblasts. 65
Possible differential markers of Alzheimer disease: SCD40 and TGFBETA 1 65
Uso "inappropriato" del Comet Assay per lo studio del processo di senescenza cellulare 65
Espressione, regolazione e possibile significato diagnostico di alterazioni biochimiche in fibroblasti di pazienti con malattia di Alzheimer 65
"Transketolase abnormalities in extracts of foreskin fibroblasts from Alzheimer patients as a biochemical marker of the disease” 64
Megakaryocyte-like increase in ploidy of Friend's erythroleukemia cells induced to endoreplication by colcemid. 64
Studio sulle cisteino-proteinasi e sui loro inibitori endogeni in cellule normali e Alzheimer 64
Constitutive expression of a megakaryocytic functional property by murine erythroleukemia (Friend) cells: the incorporation of serotonin. 64
Identification and characterization of a bipotent (eryhtroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice. 63
Regional reduction of Transketolase in thiamine-deficient rat brain 61
Design, synthesis and preliminary biological evaluation of new 1,4-benzodiazepine-based compounds as histone deacetylase inhibitors and antileukemic agents 60
Enhanced proteolytic activities in cultured fibroblasts of Alzheimer patients are revelaed by peculiar transketolase alterations 60
Modificazioni del metabolismo del colesterolo e alterazioni proteolitiche come marcatori periferici e precoci della malattia di Alzheimer 60
Unconventional Use of the Comet Assay to Identify and Classify Different Nuclear Phenotypes in Cell Cultures 59
Free Ca2+ levels and expression of biochemical markers in Alzheimer’s fibroblasts 58
Uso "inappropriato" del Comet assay per lo studio del processo di senescenza cellulare 57
Pathogenesis of myelofibrosis with myeloid metaplasia: lesson from mouse models of disease 55
Neurodegenerative diseases and protein misfolding:novel targets and new inhibitors 53
Sinergie tra marcatori periferici e fattori di rischio per una diagnosi precoce della malattia di Alzheimer 52
Totale 9.049
Categoria #
all - tutte 20.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.117 0 0 0 0 156 205 142 221 127 75 172 19
2020/20211.233 101 89 109 132 47 211 37 121 76 156 36 118
2021/2022539 9 67 25 26 21 14 19 41 23 18 157 119
2022/20231.304 142 166 69 110 133 273 130 64 131 6 44 36
2023/2024409 14 60 85 29 25 41 10 110 1 9 15 10
2024/20252.030 107 333 189 443 958 0 0 0 0 0 0 0
Totale 9.049